�����������

, who is a resident academic within the Faculty of Economics, Management and Accountancy (FEMA), has been elected and appointed Senior Fellow at the LSE Health Centre and Visiting Professor in the fields of Bioinformatics, Computational Medicine and Epidemiology at the Department of Health Policy at (LSE), after the distinguished endorsement of Elias Mossialos, Brian Abel-Smith Professor Head of Department of Health Policy LSE and Director of the LSE Health Centre. This appointment will come into effect as from January 2022. 

ranks Prof. Bekiros among the top 5% of the authors worldwide. The Newspoint team spoke with Prof. Bekiros, he said “My appointment at the LSE is a great honour and privilege, and I look forward to working with the distinguished members of the LSE Health Centre and the affiliated Department of Health Policy, in pursuit of policy-driven, cutting-edge research, to address global health challenges through the use of multidisciplinary Future Technologies. At the same time, it is a vote of confidence in the quality of our faculty and staff. It’s another step toward enhancing extroversion, reputation and visibility of the University of Malta, through collaborative research work and joint programmes”.

Furthermore. he added: "I couldn’t have accomplished this without the continuous support from the Prof. Alfred J. Vella (Rector), and Prof. Frank Bezzina (Pro-Rector for International Development and Quality Assurance)". 

At the LSE Health, Professor Bekiros will be involved among other in the application of interdisciplinary approaches, such as bioinformatics, complex systems, blockchain technologies, computational medicine, AI and quantum machine learning algorithms, for innovative drug development and disease treatment. Quantum technologies in computational biology and genetics while still in their infancy, when combined with blockchain technologies, big data science, epigenomics, AI and other multidisciplinary approaches, will revolutionise healthcare, transform governmental health policies and eventually shape the future in drug discovery and disease treatment, with an immense social impact." he concluded.